SCHEMBL699063

SCHEMBL699063

Cc1cccc([C@H](C)c2nccn2Cc2cccc(C)c2F)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 5/20 0.42
TDP1 Q9NUW8 1/20 0.36
KMT2A Q03164 2/20 0.35
KCNH2 Q12809 4/20 0.34
ADRA2A P08913 4/20 0.34
ADRA2B P18089 4/20 0.34
ADRA1A P35348 3/20 0.34
ADRA1B P35368 3/20 0.34
ADRA1D P25100 2/20 0.34
CYP2D6 P10635 2/20 0.34
TSHR P16473 2/20 0.34
CYP2C19 P33261 2/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
SLC6A2 P23975 1/20 0.33
HTR7 P34969 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL697058 0.93 ADRA2C (0.40) ADRA2CTDP1KMT2AKCNH2ADRA2A
SCHEMBL697196 0.91 ADRA2C (0.39) ADRA2CTDP1KCNH2CYP2D6TSHR
SCHEMBL698377 0.89 ADRA2C (0.44) ADRA2CTDP1KMT2AKCNH2TP53
SCHEMBL697585 0.89 ADRA2C (0.53) ADRA2CTDP1KMT2ATSHRALDH1A1
SCHEMBL3530799 0.86 ADRA2C (0.38) ADRA2CTDP1KMT2AKCNH2ADRA2A
SCHEMBL698465 0.85 ADRA2C (0.44) ADRA2CTDP1KMT2AKCNH2ADRA2A
SCHEMBL697206 0.84 KCNH2 (0.38) ADRA2CTDP1KMT2AKCNH2ADRA2A
SCHEMBL696318 0.84 PKM (0.39) ADRA2CTDP1KMT2AKCNH2ADRA2A
SCHEMBL696898 0.84 KCNH2 (0.38) ADRA2CTDP1KMT2AKCNH2CYP2D6
SCHEMBL697472 0.84 ADRA2C (0.41) ADRA2CTDP1KMT2AKCNH2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885TDP1 2820/4885KMT2A 945/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885TDP1 2820/4885KMT2A 945/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885TDP1 2820/4885KMT2A 945/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885TDP1 2820/4885KMT2A 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.